These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

647 related items for PubMed ID: 17056311

  • 21. Responses of trabecular and cortical bone turnover and bone mass and strength to bisphosphonate YH529 in ovariohysterectomized beagles with calcium restriction.
    Yoshida Y, Moriya A, Kitamura K, Inazu M, Okimoto N, Okazaki Y, Nakamura T.
    J Bone Miner Res; 1998 Jun; 13(6):1011-22. PubMed ID: 9626633
    [Abstract] [Full Text] [Related]

  • 22. Human parathyroid hormone-(1-34) prevents bone loss and augments bone formation in sexually mature ovariectomized rats.
    Liu CC, Kalu DN.
    J Bone Miner Res; 1990 Sep; 5(9):973-82. PubMed ID: 2281827
    [Abstract] [Full Text] [Related]

  • 23. Parathyroid hormone fragments may stimulate bone growth in ovariectomized rats by activating adenylyl cyclase.
    Rixon RH, Whitfield JF, Gagnon L, Isaacs RJ, Maclean S, Chakravarthy B, Durkin JP, Neugebauer W, Ross V, Sung W.
    J Bone Miner Res; 1994 Aug; 9(8):1179-89. PubMed ID: 7976500
    [Abstract] [Full Text] [Related]

  • 24. Dose-response effects of intermittent PTH on cancellous bone in hindlimb unloaded rats.
    Turner RT, Evans GL, Lotinun S, Lapke PD, Iwaniec UT, Morey-Holton E.
    J Bone Miner Res; 2007 Jan; 22(1):64-71. PubMed ID: 17042715
    [Abstract] [Full Text] [Related]

  • 25. Trabecular bone response to mechanical and parathyroid hormone stimulation: the role of mechanical microenvironment.
    Kim CH, Takai E, Zhou H, von Stechow D, Müller R, Dempster DW, Guo XE.
    J Bone Miner Res; 2003 Dec; 18(12):2116-25. PubMed ID: 14672346
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Bone anabolic effects of parathyroid hormone are blunted by deletion of the Wnt antagonist secreted frizzled-related protein-1.
    Bodine PV, Seestaller-Wehr L, Kharode YP, Bex FJ, Komm BS.
    J Cell Physiol; 2007 Feb; 210(2):352-7. PubMed ID: 17044082
    [Abstract] [Full Text] [Related]

  • 30. Osteopontin deficiency induces parathyroid hormone enhancement of cortical bone formation.
    Kitahara K, Ishijima M, Rittling SR, Tsuji K, Kurosawa H, Nifuji A, Denhardt DT, Noda M.
    Endocrinology; 2003 May; 144(5):2132-40. PubMed ID: 12697722
    [Abstract] [Full Text] [Related]

  • 31. Human parathyroid hormone 1-34 reverses bone loss in ovariectomized mice.
    Alexander JM, Bab I, Fish S, Müller R, Uchiyama T, Gronowicz G, Nahounou M, Zhao Q, White DW, Chorev M, Gazit D, Rosenblatt M.
    J Bone Miner Res; 2001 Sep; 16(9):1665-73. PubMed ID: 11547836
    [Abstract] [Full Text] [Related]

  • 32. Insulin-like growth factor I is required for the anabolic actions of parathyroid hormone on mouse bone.
    Bikle DD, Sakata T, Leary C, Elalieh H, Ginzinger D, Rosen CJ, Beamer W, Majumdar S, Halloran BP.
    J Bone Miner Res; 2002 Sep; 17(9):1570-8. PubMed ID: 12211426
    [Abstract] [Full Text] [Related]

  • 33. Intratrabecular tunneling increases trabecular number throughout the skeleton of ovariectomized rhesus monkeys treated with parathyroid hormone 1-84.
    Miller MA, Bare SP, Recker RR, Smith SY, Fox J.
    Bone; 2008 Jun; 42(6):1175-83. PubMed ID: 18387869
    [Abstract] [Full Text] [Related]

  • 34. Study on preparation and activity of a novel recombinant human parathyroid hormone(1-34) analog with N-terminal Pro-Pro extension.
    Chunxiao W, Jingjing L, Yire X, Min D, Zhaohui W, Gaofu Q, Xiangchun S, Xuejun W, Jie W, Taiming L.
    Regul Pept; 2007 Jun 07; 141(1-3):35-43. PubMed ID: 17300845
    [Abstract] [Full Text] [Related]

  • 35. Parathyroid hormone (1-34) and (1-84) stimulate cortical bone formation both from periosteum and endosteum.
    Oxlund H, Ejersted C, Andreassen TT, Tørring O, Nilsson MH.
    Calcif Tissue Int; 1993 Dec 07; 53(6):394-9. PubMed ID: 8293353
    [Abstract] [Full Text] [Related]

  • 36. Effects of a one-month treatment with PTH(1-34) on bone formation on cancellous, endocortical, and periosteal surfaces of the human ilium.
    Lindsay R, Zhou H, Cosman F, Nieves J, Dempster DW, Hodsman AB.
    J Bone Miner Res; 2007 Apr 07; 22(4):495-502. PubMed ID: 17227219
    [Abstract] [Full Text] [Related]

  • 37. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.
    Christiansen P.
    APMIS Suppl; 2001 Apr 07; (102):1-52. PubMed ID: 11419022
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Increased bone formation by intermittent parathyroid hormone administration is due to the stimulation of proliferation and differentiation of osteoprogenitor cells in bone marrow.
    Nishida S, Yamaguchi A, Tanizawa T, Endo N, Mashiba T, Uchiyama Y, Suda T, Yoshiki S, Takahashi HE.
    Bone; 1994 Apr 07; 15(6):717-23. PubMed ID: 7873302
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.